sotorasib,al102,adagrasib,nuc-7738,fruquintinib,zanidatamab zovodotin
nucana,ayala pharmaceuticalsceuticals,zymeworks,hutchmed,novartis,mirati,amgen
['zw49', 'adagrasib', 'nuc-7738', 'fruquintinib', 'al102', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'nsclc', 'sclc', 'lumakras', '$mrtx', '$amgn', '$hcm', '$ncna', '$zyme', '$ayla']
#esmo22 pres. tom. (9/12) $ayla al102 ph2/3 (#desmoidtumors)
$mrtx adagrasib ph1/2 (#crc)
$zyme zw49 ph1 (#solidcancers)
$hcm fruquintinib ph3 (#crc)
$amgn lumakras ph3 (#nsclc)
$ncna nuc-7738 ph1 (#solidtumors) see our blog for all pres. 
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. 

Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanqtbK